Shah A, Afzal M. Prevalence of diabetes and hypertension and association with various risk factors among different Muslim populations of Manipur, India. J Diabetes Metab Disord. 2013;12:1–10.

Article  Google Scholar 

Asif M. The prevention and control the type-2 diabetes by changing lifestyle and dietary pattern. J Educ health Promotion. 2014;3:1.

Article  Google Scholar 

Goyal R, Singhal, M, Jialal I. Type 2 Diabetes. [Updated 2023 Jun 23]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK513253/.2023.

Delpino FM, Figueiredo LM, da Silva BGC, da Silva TG, Mintem GC, Bielemann RM, et al. Omega-3 supplementation and diabetes: a systematic review and meta-analysis. Crit Rev Food Sci Nutr. 2022;62:4435–48.

Article  CAS  PubMed  Google Scholar 

Phatak SR, Saboo B, Dwivedi S, Zinzuwadia P, Panchal D, Ganguli A, et al. Sweetening sixteen: beyond the ominous octet. J Diabetol. 2021;12:1–9.

Article  Google Scholar 

Daryabor G, Atashzar MR, Kabelitz D, Meri S, Kalantar K. The effects of type 2 diabetes mellitus on organ metabolism and the immune system. Front Immunol. 2020;11:1582.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kyriakou T-C, Papageorgis P, Christodoulou M-I. Common genetic aberrations associated with metabolic interferences in human Type-2 diabetes and acute myeloid leukemia: a bioinformatics approach. Int J Mol Sci. 2021;22:9322.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sena CM, Bento CF, Pereira P, Seiça R. Diabetes mellitus: new challenges and innovative therapies. EPMA J. 2010;1:138–63.

Article  PubMed  PubMed Central  Google Scholar 

Griffin MD, Sanders TA, Davies IG, Morgan LM, Millward DJ, Lewis F, et al. Effects of altering the ratio of dietary n− 6 to n− 3 fatty acids on insulin sensitivity, lipoprotein size, and postprandial lipemia in men and postmenopausal women aged 45–70 y: the OPTILIP Study. Am J Clin Nutr. 2006;84:1290–8.

Article  CAS  PubMed  Google Scholar 

Steinmetz A. Treatment of diabetic dyslipoproteinemia. Exp Clin Endocrinol Diabetes. 2003;111:239–45.

Article  CAS  PubMed  Google Scholar 

Kong P, Cui Z-Y, Huang X-F, Zhang D-D, Guo R-J, Han M. Inflammation and atherosclerosis: signaling pathways and therapeutic intervention. Signal Transduct Target Ther. 2022;7:131.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nillawar AN, Joshi KB, Patil SB, Bardapurkar JS, Bardapurkar SJ. Evaluation of HS-CRP and Lipid Profile in COPD. J Clin Diagnostic Res. 2013;7:801.

Google Scholar 

Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circ Res. 2010;107:1058–70.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Asmat U, Abad K, Ismail K. Diabetes mellitus and oxidative stress—A concise review. Saudi Pharm J. 2016;24:547–53.

Article  PubMed  Google Scholar 

Bhatti JS, Sehrawat A, Mishra J, Sidhu IS, Navik U, Khullar N, et al. Oxidative stress in the pathophysiology of type 2 diabetes and related complications: Current therapeutics strategies and future perspectives. Free Radic Biol Med. 2022;184:114–34.

Article  CAS  PubMed  Google Scholar 

Maria-Luisa L-d-l-V-M, Cristina F-M. Oxidative stress in diabetes mellitus and the role of vitamins with antioxidant actions. In: José AM-G, editor. Oxidative Stress and Chronic Degenerative Diseases. Rijeka: IntechOpen; 2013. p. 9.

Kannel WB. Lipids, diabetes, and coronary heart disease: insights from the Framingham Study. Am heart J. 1985;110:1100–7.

Article  CAS  PubMed  Google Scholar 

Solano MP, Goldberg RB. Lipid management in Type 2 diabetes. Clin Diabetes. 2006;24:27–32.

Article  Google Scholar 

Blum A, Socea D, Ben-Shushan RS, Keinan-Boker L, Naftali M, Segol G, et al. A decrease in VEGF and inflammatory markers is associated with diabetic proliferative retinopathy. Eur Cytokine Netw. 2012;23:158–62.

Article  CAS  PubMed  Google Scholar 

Zhang Q, Fang W, Ma L, Wang Z-D, Yang Y-M, Lu Y-Q. VEGF levels in plasma in relation to metabolic control, inflammation, and microvascular complications in type-2 diabetes: a cohort study. Medicine 2018;97:e0415.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen J, Gu Z, Wu M, Yang Y, Zhang J, Ou J, et al. C-reactive protein can upregulate VEGF expression to promote ADSC-induced angiogenesis by activating HIF-1α via CD64/PI3k/Akt and MAPK/ERK signaling pathways. Stem Cell Res Ther. 2016;7:1–13.

Article  Google Scholar 

Castoldi G, Galimberti S, Riva C, Papagna R, Querci F, Casati M, et al. Association between serum values of C-reactive protein and cytokine production in whole blood of patients with type 2 diabetes. Clin Sci. 2007;113:103–8.

Article  CAS  Google Scholar 

Kim D-C, Ku S-K, Lee W, Bae J-S. Barrier protective activities of curcumin and its derivative. Inflamm Res. 2012;61:437–44.

Article  CAS  PubMed  Google Scholar 

Micallef M, Munro I, Garg M. An inverse relationship between plasma n-3 fatty acids and C-reactive protein in healthy individuals. Eur J Clin Nutr. 2009;63:1154–6.

Article  CAS  PubMed  Google Scholar 

Güttler N, Zheleva K, Parahuleva M, Chasan R, Bilgin M, Neuhof C, et al. Omega-3 Fatty acids and vitamin d in cardiology. Cardiol Res Pract. 2012;2012:729670.

Article  PubMed  PubMed Central  Google Scholar 

Erkkilä AT, Lichtenstein AH, Mozaffarian D, Herrington DM. Fish intake is associated with a reduced progression of coronary artery atherosclerosis in postmenopausal women with coronary artery disease. Am J Clin Nutr. 2004;80:626–32.

Article  PubMed  Google Scholar 

Sun L-N, Yang Z-Y, Lv S-S, Liu X-C, Guan G-J, Liu G. Curcumin prevents diabetic nephropathy against inflammatory response via reversing caveolin-1 Tyr14 phosphorylation influenced TLR4 activation. Int Immunopharmacol. 2014;23:236–46.

Article  CAS  PubMed  Google Scholar 

Pari L, Tewas D, Eckel J. Role of curcumin in health and disease. Arch Physiol Biochem. 2008;114:127–49.

Article  CAS  PubMed  Google Scholar 

Hu FB, Cho E, Rexrode KM, Albert CM, Manson JE. Fish and long-chain ω-3 fatty acid intake and risk of coronary heart disease and total mortality in diabetic women. Circulation 2003;107:1852–7.

Article  PubMed  Google Scholar 

Nettleton JA, Katz R. n-3 long-chain polyunsaturated fatty acids in type 2 diabetes: a review. J Am Dietetic Assoc 2005;105:428–40.

Article  CAS  Google Scholar 

Li D. Omega-3 fatty acids and non-communicable diseases. Chin Med J. 2003;116:453–8.

CAS  PubMed  Google Scholar 

Huh JH, Jo SH. Omega-3 fatty acids and atrial fibrillation. Korean J Intern Med. 2023;38:282–9.

Article  CAS  PubMed  Google Scholar 

Curfman G. Omega-3 fatty acids and atrial fibrillation. JAMA. 2021;325:1063.

Article  PubMed  Google Scholar 

Fatkin D, Cox CD, Martinac B. Fishing for links between omega-3 fatty acids and atrial fibrillation. Circulation 2022;145:1037–9.

Article  CAS  PubMed  Google Scholar 

Gayathri K, Bhaskaran M, Selvam C, Thilagavathi R. Nano formulation approaches for curcumin delivery- a review. J Drug Deliv Sci Technol. 2023;82:104326.

Article  CAS  Google Scholar 

Hegde M, Girisa S, BharathwajChetty B, Vishwa R, Kunnumakkara AB. Curcumin formulations for better bioavailability: what we learned from clinical trials thus far? ACS Omega. 2023;8:10713–46.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Karthikeyan A, Senthil N, Min T. Nanocurcumin: a promising candidate for therapeutic applications. Front Pharmacol. 2020;11:487.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shamsi-Goushki A, Mortazavi Z, Mirshekar MA, Mohammadi M, Moradi-Kor N, Jafari-Maskouni S, et al. Comparative effects of curcumin versus nano-curcumin on insulin resistance, serum levels of apelin and lipid profile in type 2 diabetic rats. Diabetes Metab Syndr Obes 2020;13:2337–46.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rahimi HR, Nedaeinia R, Sepehri Shamloo A, Nikdoust S, Kazemi Oskuee R. Novel delivery system for natural products: Nano-curcumin formulations. Avicenna J Phytomed. 2016;6:383–98.

CAS  PubMed  PubMed Central  Google Scholar 

Pal A, Metherel AH, Fiabane L, Buddenbaum N, Bazinet RP, Shaikh SR. Do eicosapentaenoic acid and docosahexaenoic acid have the potential to compete against each other? Nutrients 2020;12:3718.

Article  CAS  PubMed  PubMed Central  Google Scholar